Characterization of the Melanoma-Specific Immune Response
N/A
The aim of this study is to study T-cells. Blood will be collected and the ...
Status
Unknown
Location
University of California, Davis Department of Dermatology
Start Date
2007-08
Trial ID
NCT00368615
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above
PHASE3
To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vacc...
A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
PHASE1
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit